newsfilter
← Latest News
GlobeNewswire·

Celcuity To Participate in Upcoming Investor Conferences

MINNEAPOLIS, May 28, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company focused on the development of targeted therapies for the treatment of multiple solid tumor indications,